Philip Kern: Clinical Trials

9 trials sponsored by Philip Kern, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 not yet recruiting. 3 Early Phase 1, 2 Not applicable, 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 3
Not applicable2Completed 1, Not yet recruiting 1
Phase 22Completed 1, Recruiting 1
Phase 42Completed 1, Recruiting 1

Follow Philip Kern: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RELIANCE: Moringa in Lactation and Early Childhood
Moringa Leaf Powder, Carrier - Breast Feeding, Lactation
Not applicableNot yet recruitingPhilip Kern1002026-11-012026-07-17
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
Mirabegron 50 MG, Tadalafil 10 MG, Placebo - Pre-diabetes, Obesity
Phase 4RecruitingPhilip Kern962021-12-132026-08-31
Mechanisms for Activation of Beige Adipose Tissue in Humans
Placebo, Mirabegron, Mirabegron 50 MG - PreDiabetes
Phase 2RecruitingPhilip Kern652020-12-072026-11-19
Brown Fat Activation Study
Mirabegron, Pioglitazone, Mirabegron and Pioglitazone - Obese, Metabolic Syndrome
Early Phase 1CompletedPhilip Kern392016-09-012020-02-07
Cold Induced Changes in White Adipose
Fat biopsy, Propranolol and fat biopsy, heavy water and fat biopsy - Obese, Normal Body Weight
Early Phase 1CompletedPhilip Kern262016-03-012020-02-07
Blood Lipopolysaccharide (LPS) Rifaximin Study
Rifaximin SSD, Placebo - Obese, Insulin Resistance
Phase 2CompletedPhilip Kern122015-03-012019-08-21
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Progressive Resistance Training, Metformin - Aging
Early Phase 1CompletedPhilip Kern1092015-01-142019-09-17
Effects of Fish Oils on Inflammation and Insulin Resistance
omega-3 fatty acid, placebo - Metabolic Syndrome, Insulin Resistance
Not applicableCompletedPhilip Kern332007-01-012018-05-16
Mechanisms Underlying Metabolic Syndrome in Obesity
Pioglitazone - Metabolic Syndrome, Insulin Resistance
Phase 4CompletedPhilip Kern702005-04-012017-06-15

Conditions studied

Obesity (6)  ·  Metabolic Syndrome (5)  ·  Diabetes Mellitus (3)  ·  Insulin Resistance (3)  ·  Prediabetic State (3)  ·  Inflammation (2)  ·  Breast Feeding (1)  ·  Glucose Intolerance (1)  ·  Hypertrophy (1)  ·  Platelet Glycoprotein IV Deficiency (1)

Interventions

mirabegron (3)  ·  Pioglitazone (2)  ·  Carrier State (1)  ·  Deuterium Oxide (1)  ·  Fatty Acids, Omega-3 (1)  ·  Metformin (1)  ·  Omacor (1)  ·  Propranolol (1)  ·  Resistance Training (1)  ·  Tadalafil (1)

Countries

United States (9)

Top investigators

Charlotte Peterson, Ph.D. (1)  ·  Marcas Bamman, Ph.D (1)  ·  Phililp Kern, MD (1)  ·  Philip A. Kern, M.D. (1)

Results publications

PMID 30089732, PMID 23328126, PMID 28441958, PMID 30730923, PMID 31557380, PMID 31961829, PMID 33462708, PMID 33571166, PMID 35492586, PMID 35894077

NIH funding

P20RR021954 (1), R01DK071277 (1), R01DK107646 (1), R01DK112282 (1), R01DK124626 (1), R01DK128033 (1), R21DK100258 (1), UL1TR000117 (1)